3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Endometrial Neoplasms
3
Stomach Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Thrombophilia
1
Thrombocytopenia
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Cancer Extensive Stage
1
Salivary Gland Neoplasms
1
Pathologic Complete Response
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Myelosuppression
1
Myeloproliferative Disorders
1
Mouth Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukopenia
1
Leiomyoma
1
Hypersplenism
1
Hemoglobinuria, Paroxysmal
1
Hematologic Diseases
1
Growth Hormone-Secreting Pituitary Adenoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Liver Metastases
1
Interventions
selinexor
1
peginterferon alfa-2b
1
Specimen Handling
1
Resistance Training
1
Quality of Life
1
Phlebotomy
1
Observation
1
Maintenance
1
Levofloxacin
1
Exercise
1
Electrocardiography
1
Echocardiography
1
Clinical Laboratory Techniques
1
Busulfan
1
Bone Marrow Examination
1
Biopsy
1
Azacitidine
1
Aspirin
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Myeloproliferative Disorders
×
Observation
×
Clear all
NCT07108023
2025-08-06
EHPVO-HEM
Assiut University
Not yet recruiting
115 enrolled